Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 22, 2021, titled "Sun Pharma Announces Settlement of Patent Litigation forGeneric Revlimid�� (lenalidomide) in US".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 22, 2021, titled "Sun Pharma Announces Settlement of Patent Litigation forGeneric Revlimid�� (lenalidomide) in US".